semaglutide approved for cardiovascular Updates in Medicine | Not just weight loss anymore — is now part of risk reduction. 🫀 FDA approves Ozempic to reduce

Regular monitoring is important, especially in patients with ongoing liver-related conditions

Ozempic and Wegovy - Diabetes Mellitus and Weight Loss Treatment FDA approved for Weight loss - covered by some insurance

Semaglutide users often come from a background of no injection experience, and the syringe markings are designed for insulin dosing, not peptide dosing

Drugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide

[76] found no evidence of increased risk of suicidal ideation and self-injury associated with GLP-1 RAs compared to SGLT-2 inhibitors in individuals with T2DM and obesity, based on data from the Valencia Health System Integrated Database (VID) (per-protocol analysis: HR, 1.04